PCRX
Pacira Biosciences Inc
Price:  
20.33 
USD
Volume:  
681,026.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PCRX WACC - Weighted Average Cost of Capital

The WACC of Pacira Biosciences Inc (PCRX) is 7.4%.

The Cost of Equity of Pacira Biosciences Inc (PCRX) is 9.35%.
The Cost of Debt of Pacira Biosciences Inc (PCRX) is 5.50%.

Range Selected
Cost of equity 7.90% - 10.80% 9.35%
Tax rate 23.10% - 28.10% 25.60%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.1% - 8.7% 7.4%
WACC

PCRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.87 1.06
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.90% 10.80%
Tax rate 23.10% 28.10%
Debt/Equity ratio 0.59 0.59
Cost of debt 4.00% 7.00%
After-tax WACC 6.1% 8.7%
Selected WACC 7.4%